Autolus Therapeutics PLC (FRA:6A3A)
€ 3.22 0.02 (0.63%) Market Cap: 856.91 Mil Enterprise Value: 285.19 Mil PE Ratio: 0 PB Ratio: 1.85 GF Score: 57/100

Autolus Therapeutics PLC at Goldman Sachs Global Healthcare Conference (Virtual) Transcript

Jun 10, 2020 / 01:40PM GMT
Release Date Price: €12.5 (+10.62%)
Graig Suvannavejh
Goldman Sachs Group, Inc., Research Division - Executive Director & Senior Equity Research Analyst

Okay. Good morning, everyone. Welcome to the 9:40 session of the Goldman Sachs Global Healthcare Conference. My name is Graig Suvannavejh. I cover European and U.S. biopharma for the firm.

I've got the great pleasure of hosting Autolus this morning. And with us from the company are Christian Itin, Chairman and CEO of the company; as well as Andrew Oakley, who's the Chief Financial Officer of the company. So with that, thank you both for joining us.

Questions & Answers

Graig Suvannavejh
Goldman Sachs Group, Inc., Research Division - Executive Director & Senior Equity Research Analyst

Perhaps what I'll do is I'll just start from a very high level, and I'll start with you, Christian. CEO of the company, and you've been with the company from relatively early days. But if you could tell us kind of where the company is today relative to kind of the original vision of the company, and how do you feel you're executing on

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot